UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 320

Sortiert nach

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Journal of clinical oncology, 2006-10, Vol.24 (29), p.4738-4745

2006

Volltextzugriff (PDF)

Naturally occurring B-cell responses to breast cancer

Cancer Immunology, Immunotherapy, 2003-12, Vol.52 (12), p.715-738

2003

Volltextzugriff (PDF)

Clinical applications of dendritic cell vaccination in the treatment of cancer

Cancer Immunology, Immunotherapy, 2004-04, Vol.53 (4), p.275-306

2004

Volltextzugriff (PDF)

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

Journal of clinical oncology, 2009-12, Vol.27 (36), p.6207-6212

2009

Volltextzugriff (PDF)

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

Journal of translational medicine, 2010-09, Vol.8 (1), p.89-89, Article 89

2010

Volltextzugriff (PDF)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Investigational new drugs, 2011-06, Vol.29 (3), p.489-498

2011

Volltextzugriff (PDF)

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2285-2291

2001

Volltextzugriff (PDF)

A phase 2 clinical trial of nab‐paclitaxel in previously treated and chemotherapy‐naive patients with metastatic melanoma

Cancer, 2010-01, Vol.116 (1), p.155-163

2010

Volltextzugriff (PDF)

A new type of synthetic peptide library for identifying ligand-binding activity

Nature (London), 1991-11, Vol.354 (6348), p.82-84

1991

Volltextzugriff (PDF)

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Clinical Medicine Insights. Oncology, 2012-01, Vol.2012 (6), p.275-286

2012

Volltextzugriff (PDF)

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Clinical cancer research, 2000-10, Vol.6 (10), p.3904-3909

2000

Volltextzugriff (PDF)

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast

The Journal of immunology (1950), 2002-08, Vol.169 (4), p.1829-1836

2002

Volltextzugriff (PDF)

Whole-brain radiation therapy in melanoma: an open question

The lancet oncology, 2010, Vol.11 (1), p.13-13

2010

Volltextzugriff (PDF)

phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2010-07, Vol.66 (2), p.287-294

2010

Volltextzugriff (PDF)

Alpha interferon for induction of remission in hairy-cell leukemia

The New England journal of medicine, 1984-01, Vol.310 (1), p.15

1984

Volltextzugriff (PDF)

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

Cancer Immunology, Immunotherapy, 2004-08, Vol.53 (8), p.705-714

2004

Volltextzugriff (PDF)

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of oncology, 2015-11, Vol.26 (11), p.2267-2274

2015

Volltextzugriff (PDF)

Rodent models of brain metastasis in melanoma

Melanoma research, 2005-10, Vol.15 (5), p.325-356

2005

Volltextzugriff (PDF)

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

Cancer Immunology, Immunotherapy, 2001-10, Vol.50 (8), p.397-407

2001

Volltextzugriff (PDF)

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: A Southwest Oncology Group Study

Cancer, 2004-04, Vol.100 (8), p.1699-1704

2004

Volltextzugriff (PDF)

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2001, Vol.47 (1), p.83-88

2001

Volltextzugriff (PDF)

Pharmacokinetics of recombinant interleukin 2 in humans

Cancer research (Chicago, Ill.), 1990-04, Vol.50 (7), p.2009-2017

1990

Volltextzugriff (PDF)

Feasibility to Generate Monocyte-Derived Dendritic Cell from Coculture with Melanoma Tumor Cells in the Presence of Granulocyte / Macrophage Colony-Stimulating Factor (GM-CSF) and Interleukin-4

American journal of reproductive immunology (1989), 2003-04, Vol.49 (4), p.230-238

2003

Volltextzugriff (PDF)

Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells

Cancer gene therapy, 1999-09, Vol.6 (5), p.437-446

1999

Volltextzugriff (PDF)

Novel Antitumor 2-Cyanoaziridine-1-carboxamides

Journal of medicinal chemistry, 1999-02, Vol.42 (3), p.510-514

1999

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(295)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Englisch
(320)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

Naturally occurring B-cell responses to breast cancer

Clinical applications of dendritic cell vaccination in the treatment of cancer

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

A phase 2 clinical trial of nab‐paclitaxel in previously treated and chemotherapy‐naive patients with metastatic melanoma

A new type of synthetic peptide library for identifying ligand-binding activity

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Loss of B7.2 (CD86) and Intracellular Adhesion Molecule 1 (CD54) Expression Is Associated with Decreased Tumor-infiltrating T Lymphocytes in Diffuse B-cell Large-cell Lymphoma

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast

Whole-brain radiation therapy in melanoma: an open question

phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Alpha interferon for induction of remission in hairy-cell leukemia

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Rodent models of brain metastasis in melanoma

Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: A Southwest Oncology Group Study

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

Pharmacokinetics of recombinant interleukin 2 in humans

Feasibility to Generate Monocyte-Derived Dendritic Cell from Coculture with Melanoma Tumor Cells in the Presence of Granulocyte / Macrophage Colony-Stimulating Factor (GM-CSF) and Interleukin-4

Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells

Novel Antitumor 2-Cyanoaziridine-1-carboxamides

Suchergebnisse filtern